RE:RE:RE:RE:yankee- you make a good point
They have made some impressive progress in mice. While they have the same market capitalization as Bioniche their patients are still rodents. MCNA has cured cancer in a small town's population of humans, many of whom may otherwise die,with no side effects.and they are submitting for a marketing license with the FDA in March. The most interesting thing about TLT is that their pre clinical work in mice drives the same value as a company a decade and a half ahead of them with a pending submission to the FDA. The same market cap as Bioniche, for pre clinical work on mice!